Skip to main content
. 2020 Nov 20;10:595804. doi: 10.3389/fonc.2020.595804

Figure 3.

Figure 3

Assessing recent systemic anti-cancer therapy (SACT) as a predictor of mortality following COVID-19 (A) Adjusted survival curves of patients on systemic anti-cancer therapy with COVID-19. (B) Multivariate survival analysis of pre-morbid risk factors in patients with cancer and COVID-19.